UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 Current Report


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of report (date of earliest event reported): December 11, 2009

                               Balchem Corporation
             (Exact name of registrant as specified in its charter)

Maryland                               1-13648                  13-257-8432
(State or other jurisdiction of      (Commission               (IRS Employer
incorporation)                       File Number)            Identification No.)

                       P.O. Box 600, New Hampton, NY 10958
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (845) 326-5600

      Check the  appropriate  box below if the Form 8-K  filing is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

[_]   Written  communications  pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)

[_]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)

[_]   Pre-commencement  communications  pursuant  to  Rule  14d-2(b)  under  the
      Exchange Act (17 CFR 240.14d-2(b))

[_]   Pre-commencement  communications  pursuant  to  Rule  13e-4(c)  under  the
      Exchange Act (17 CFR 240.13e-4(c))








Item 7.01: Regulation FD.

On December 11, 2009,  the Company  issued a press release  announcing  that its
Board of Directors has voted to approve a 3-for-2 stock split, to be effected in
the form of a stock dividend,  and also a cash dividend of $0.11 per share.  For
purposes of the cash dividend,  the number of outstanding shares of Common Stock
to which it will apply will give effect to the stock  dividend.  Both  dividends
will be payable on January 20, 2010 to stockholders of record as of December 30,
2009.  A copy of the  press  release  is  filed  herewith  as  Exhibit  99.1 and
incorporated by reference herein.

The  information in this Form 8-K  (including  Exhibit 99.1) shall not be deemed
"filed" for purposes of Section 18 of the  Securities  Exchange Act of 1934 (the
"Exchange  Act") or otherwise  subject to the  liabilities of that section,  nor
shall it be deemed  incorporated by reference in any filing under the Securities
Act of 1933 or the  Exchange  Act,  except as  expressly  set forth by  specific
reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(c) Exhibits

Exhibit 99.1   Press Release of Balchem Corporation, dated December 11, 2009.






                                    SIGNATURE

      Pursuant to the  requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                            BALCHEM CORPORATION


                                            By:/s/ Dino A. Rossi
                                            ------------------------------------
                                            Dino A. Rossi, President &
                                            Chief Executive Officer

Dated: December 11, 2009





                                  Exhibit Index


Exhibit Number     Description
- --------------     -----------


99.1               Press Release of Balchem Corporation dated December 11, 2009.